Company family
メディサ新薬: medicine shortages
As of 2 Nov 2026, 3 メディサ新薬 products have a reported shortage across 1 countries, covering 2 medicines.
Products short3rank #446 of 464
Medicines2active ingredients
Countries1/16
New in 90 days1-1 vs market pace
Typical duration5 monthsmedian so far
Manufacturing0%demand-driven 0%
Where
Which therapeutic classes
Why, compared with all companies
Manufacturing problemIncreased demandActive ingredient shortageDistribution or logisticsCommercial decision or withdrawalRegulatory or licensingOtherNot stated
Manufacturing problems point to the company's own supply chain; increased demand often follows a competitor's shortage or a demand shock.
Latest changes
All changesNo changes recorded yet. Changes are tracked from our daily snapshots.
When its current shortages began
Against its peers
Breadth vs depth
Further right: more products short. Higher: more different medicines affected.
Medicines short
Download CSV| Medicine | Where this company is short | Products | Earliest start | Main reason | Short anywhere |
|---|---|---|---|---|---|
| Nicorandil | 1 | 28 May 2026 | Quality problem or recall | 3/16 | |
| Omeprazole | 1 | 28 Aug 2026 | Quality problem or recall | 8/16 |
Shortage data describes supply, not company finances. A shortage can mean lost sales for the supplier or extra demand for its competitors. Nothing here is investment advice; tickers are for identification only and may be out of date.